United States · FDA National Drug Code directory
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57664-953_10af8563-97ec-8a5e-e063-6394a90a52f8
- Product NDC
- 57664-953
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240201
- Source listing expiry
- 20261231
Source-listed ingredients
- DEXTROAMPHETAMINE SACCHARATE — 12.5 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE — 12.5 mg/1
- DEXTROAMPHETAMINE SULFATE — 12.5 mg/1
- AMPHETAMINE SULFATE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (57664-953-88) · 57664-953-88
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →